truemedinc.com

What It Is

TrueMed is a Finland-based AI platform for pharmaceutical anti-counterfeiting, focused on counterfeit medication detection and identifying diverted products. Using digital image capture devices such as smartphone cameras and desktop scanners, it combines machine learning with visual analysis to evaluate features on existing packaging, including print quality, alignment, and tiny defects. Its key positioning is “non-additive”: it does not require adding stickers, ink, QR codes, holograms, or serialization changes to the drug product or packaging.

Core Capabilities and Deployment

The product suite includes Digital Lab, Digital Field, and Consumer App. Digital Lab is designed for forensic analysis and high-throughput laboratory testing, and can be used by customs labs, QA teams, and internal investigations. Digital Field is better suited to field personnel, regulators, or supply chain partners who need instant verification in global markets. Consumer App allows patients or consumers to check products themselves. The platform supports formats such as tablets, capsules, blister packs, outer packaging, injectables, and vials. It can return an authentic, suspicious, or counterfeit result within seconds, along with a confidence score, metadata, and timestamped visual evidence, making it useful for law enforcement, regulatory reporting, and customs seizures.

Pricing and Integration

The website does not disclose specific pricing, plans, or billing units. It only offers a Request Demo / contact sales entry point, while describing the solution as cost-effective with high ROI. Integration details are relatively clear: it can be embedded into existing lab workflows, backend systems, production-line cameras, and returns processing systems, and can also be used alongside existing security measures. For pharmaceutical companies that do not want to modify their manufacturing process, this is its main value proposition.

Pros and Cons

The advantages are its low deployment barrier and ability to scan with a smartphone without additional hardware, making it suitable for cross-regional supply chains and on-site verification in high-risk markets. It also covers scenarios such as lab forensics, batch testing, and returns fraud. The drawbacks are that public materials do not specify model accuracy, false-positive/false-negative rates, data security architecture, compliance certifications, or third-party validation results. Before procurement, buyers should run a PoC to verify stability across different packaging batches, regional versions, and lighting conditions.

Who It’s For and Access from China

TrueMed is best suited to pharmaceutical brand protection teams, regulators, customs authorities, QA laboratories, and drug returns management teams, especially organizations that need to quickly identify counterfeit drugs, repackaged products, relabeled products, or cross-region diverted products in high-risk markets. The materials mention that it is effective in high-risk markets such as China, Southeast Asia, and Latin America, but do not state whether it is directly accessible from mainland China, whether local payment is supported, or whether data residency is available. Therefore, its access status from China is unknown. Domestic alternatives should be assessed separately based on drug traceability codes, anti-counterfeit labels, packaging visual inspection, or local compliance requirements.